Application of surface roughness analysis on micro-computed tomographic images of bone erosion: Examples using a rodent model of rheumatoid arthritis

Molecular Imaging

Volumn 5, Issue 4, 2006, Pages 475-484

  Silva, Matthew D ^a   Ruan, Jason ^a   Siebert, Elizabeth ^a   Savinainen, Anneli ^a   Jaffee, Bruce ^a   Schopf, Lisa ^a   Chandra, Sudeep ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE EROSION; COLLAGEN INDUCED ARTHRITIS (CIA); METHOTREXATE; MICRO COMPUTED TOMOGRAPHIC DATA;

ALGORITHMS; DRUG THERAPY; MATHEMATICAL MODELS; MEDICAL IMAGING; ORTHOPEDICS; ROBUSTNESS (CONTROL SYSTEMS); SURFACE ROUGHNESS; TOMOGRAPHY;

BONE;

IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ALGORITHM; ANIMAL; ARTHRITIS; ARTICLE; AUDIOVISUAL EQUIPMENT; BONE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; IMAGE QUALITY; LEWIS RAT; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; RAT; RHEUMATOID ARTHRITIS; SURFACE PROPERTY;

ALGORITHMS; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BONE AND BONES; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; MODELS, ANATOMIC; PHANTOMS, IMAGING; RATS; RATS, INBRED LEW; SURFACE PROPERTIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846445680     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2006.00025     Document Type: Article

References (40)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Scutellari PN, Orzincolo C. Rheumatoid arthritis: sequences. Eur J Radiol 1998;27 Suppl 1:S31-8.
3. ACR Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-46.
4. McGonagle D, Conaghan PG, Wakefield R, Emery P. Imaging the joints in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:91-104.
5. Backhaus M, Burmester GR, Sandrock D, et al. Prospective two year follow up study comparing novel and conventional imaging procedures in patients with arthritic finger joints. Ann Rheum Dis 2002;61:895-904.
6. Ory PA. Interpreting radiographic data in rheumatoid arthritis. Ann Rheum Dis 2003;62:597-604.
7. Barck KH, Lee WP, Diehl LJ, et al. Quantification of cortical bone loss and repair for therapeutic evaluation in collagen-induced arthritis, by micro-computed tomography and automated image analysis. Arthritis Rheum 2004;50:3377-86.
8. Goldring SR, Gravallese EM. Pathogenesis of bone lesions in rheumatoid arthritis. Curr Rheumatol Rep 2002;4:226-31.
9. Dixey J, Solymossy C, Young A (on behalf of the Early RA Study (ERAS). Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS). J Rheumatol Suppl 2004;69:48-54.
10. Scott DL. Radiological progression in established rheumatoid arthritis. J Rheumatol Suppl 2004;69:55-65.
11. Backhaus M, Kamradt T, Sandrock D, et al. Arthritis of the finger joints: a comprehensive approach comparing conventional radiography, scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging. Arthritis Rheum 1999;42:1232-45.
12. Peterfy CG. Magnetic resonance imaging in rheumatoid arthritis: current status and future directions. J Rheumatol 2001;28:1134-42.
13. Ostergaard M, Hansen M, Stoltenberg M, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum 2003;48:2128-31.
14. Moving JL, Buchbinder R, Hall S, et al. A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. J Rheumatol 2004;31:663-75.
15. Silva MD, Savinainen A, Kapadia R, et al. Quantitative microCT imaging and histopathological signatures of rheumatoid arthritis in rats. Mol Imaging 2004;3:312-7.
16. Lorensen WE, Cline HE. Marching cubes: a high resolution 3D surface construction algorithm. ACM SIGGRAPH Computer Graphics 1987;21:163-9.
17. Romas E, Gillespie MR, Martin TJ. Involvement of receptor activator NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 2002;30:340-6.
18. Kapadia RD, Stroup GB, Badger AM, et al. Application of micro-CT and MR microscopy to study pre-clinical models of osteoporosis and osteoarthritis. Technol Health Care 1998;6:361-72.
19. Bradbeer IN, Kapadia RD, Sarkar SK, et al. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements. Arthritis Rheum 1996;39:504-14.
20. Badger AM, Griswold DE, Kapadia R, et al. Disease-modifying activity of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, I rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:175-83.
21. Badger AM, Blake S, Kapadia R, et al. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis. Arthritis Rheum 2001;44:128-37.
22. Kapadia RD, Badger AM, Levin JM, et al. Meniscal ossification in spontaneous osteoarthritis in the guinea-pig. Osteoarthritis Cartilage 2000;8:374-7.
23. Borah B, Gross GJ, Dufresne TE, et al. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat Rec 2001;265:101-10.
24. Kremer JM. Toward a better understanding of methotrexate. Arthritis Rheum 2004;50:1370-82.
25. Weinblatt ME, Kremer JM, Bankhurst AD, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999;340:253-9.
26. Bankhurst AD. Etanercept and methotrexate combination therapy. Clin Exp Rheumatol 1999;17(6 Suppl 18):S69-72.
27. Klareskog L, van der Heijde D, de Jager JP, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004;363:675-81.
28. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
29. Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl I Med 2000;343:1594-602.
30. Breedveld FC, Emery P, Keystone E, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004;63:149-55.
31. Weinblatt ME, Kremer JM, Coblyn JS, et al. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 1999;42:1322-8.
32. Kremer IM. Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 1999;29:14-26.
33. Kalden JR, Smolen IS, Emery P, van Riel PL, et al. Leflunomide in combination therapy. J Rheumatol Suppl 2004;71:25-30.
34. Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003;48:35-45.
35. Weisman MH, Moreland LW, Furst DE, et al. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Clin Ther 2003;25:1700-21.
36. Kovalev VA, Petrou M, Bondar YS. 3D surface roughness quantification. British Machine Vision Conference, September 1997, Colchester, UK, 1997. p. 450-8.
37. Free SL, Sisodiya SM, Cook MJ, et al. Three-dimensional fractal analysis of the white matter surface from magnetic resonance images of the human brain. Cereb Cortex 1996;6:830-6.
38. Liu JZ, Zhang LD, Yue GH. Fractal dimension in human cerebellum measured by magnetic resonance imaging. Biophys J 2003;85:4041-6.
39. Sawase T, Wennerberg A, Hallgren C, et al. Chemical and topographical surface analysis of five different implant abutments. Clin Oral Implants Res 2000;11:44-50.
40. Mazor Z, Cohen DK. Preliminary 3-dimensional surface texture measurement and early loading results with a microtextured implant surface. Int J Oral Maxillofac Implants 2003;18:729-38.